Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael W. Sill
A Phase II Evaluation of Lapatinib in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
A Phase II Evaluation of Selumetinib (AZD6244, ARRY-142886), a Selective MEK-1/2 Inhibitor in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
A Phase II Evaluation of Nintedanib (BIBF-1120) in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
A Phase I Study of Concurrent Weekly Topotecan and Cisplatin Chemotherapy With Whole Pelvic Radiation Therapy in Locally Advanced Cervical Cancer: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Related publications
New Developments in the Diagnosis and Treatment of Thyroid Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
No Cost or Safety Advantage to Robot-Assisted Radical Prostatectomy Compared With Open-Procedure Surgery for Patients With Prostate Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Challenges in Ductal Carcinoma in Situ Risk Communication and Decision-Making
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Risk Factors, Pathophysiology, and Treatment of Hot Flashes in Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Angiogenesis Inhibitors: Current Strategies and Future Prospects
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Population-Based Programs for Increasing Colorectal Cancer Screening in the United States
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cancer Treatment and Survivorship Statistics, 2019
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Germline Mutations in Pancreatic Cancer Become Better Defined
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening
CA - A Cancer Journal for Clinicians
Oncology
Hematology
